Skip to main content
Premium Trial:

Request an Annual Quote

Losses and Lack of Cash at Sequenom Causes Its Accounting Firm to Identify Going Concern in 2005 Results

NEW YORK, April 7 (GenomeWeb News) - Sequenom's accounting firm has issued a "going concern qualification" on the company's financial statements for the year 2005, the company said yesterday.

 

Ernst & Young, Sequenom's independent registered public accounting firm, issued the concern on the 2005 results, filed on March 31, because of the company's significant operating losses and insufficient cash and investments to fund operations past the second quarter of 2006.

 

Last week, the company announced a private stock placement of $30 million, which it increased to $33 million on Monday.

 

As of Dec. 31, 2005, the company had $8.7 million in cash, cash equivalents, short-term investments and restricted cash. Net losses for 2005 declined to $26 million from $34 million year over year.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.